Free Trial

Calidi Biotherapeutics (CLDI) SEC Filings & 10K Form

Calidi Biotherapeutics logo
$5.30 +0.26 (+5.16%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$5.25 -0.05 (-1.02%)
As of 08/15/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Calidi Biotherapeutics SEC Filings

DateFilerForm TypeView
08/15/2025
4:21 PM
Calidi Biotherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/14/2025
8:05 PM
ARMISTICE CAPITAL, LLC (Filed by)
Calidi Biotherapeutics (Subject)
Form SCHEDULE 13G/A
08/14/2025
4:18 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2025
3:35 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2025
3:46 PM
Calidi Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2025
4:00 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2025
4:17 PM
Calidi Biotherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/15/2025
7:42 PM
Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
7:42 PM
Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
7:42 PM
Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
7:42 PM
Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2025
11:15 PM
Calidi Biotherapeutics (Filer)
Form EFFECT
07/11/2025
4:10 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2025
12:02 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2025
12:20 PM
Calidi Biotherapeutics (Filer)
Form 424B3
07/10/2025
12:20 PM
Calidi Biotherapeutics (Filer)
Form 424B3
07/03/2025
4:27 PM
Calidi Biotherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/15/2025
2:14 PM
ARMISTICE CAPITAL, LLC (Filed by)
Calidi Biotherapeutics (Subject)
Form SCHEDULE 13G
05/14/2025
3:45 PM
Calidi Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2025
3:30 PM
Calidi Biotherapeutics (Filer)
Form PRE 14A
05/02/2025
3:30 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
5:01 AM
Calidi Biotherapeutics (Issuer)
Poma Eric E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/25/2025
5:05 AM
Calidi Biotherapeutics (Issuer)
Poma Eric E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2025
7:10 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
8:57 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
5:07 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:52 PM
Calidi Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2025
5:00 AM
Calidi Biotherapeutics (Filer)
Form 424B5
03/10/2025
4:21 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:28 PM
Calidi Biotherapeutics (Filer)
Form 8-K/A
02/09/2025
11:15 PM
Calidi Biotherapeutics (Filer)
Form EFFECT
02/05/2025
5:27 AM
Calidi Biotherapeutics (Filer)
Form 424B5
01/28/2025
7:30 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:58 PM
Calidi Biotherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/10/2025
3:24 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:30 AM
Calidi Biotherapeutics (Filer)
Form 424B5
01/10/2025
7:30 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:01 PM
Calidi Biotherapeutics (Filer)
Form 424B5
01/03/2025
4:25 PM
Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:27 PM
Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2024
11:15 PM
Calidi Biotherapeutics (Filer)
Form EFFECT
New law could create $3.7 trillion tsunami. (Ad)

During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.

12/18/2024
8:29 PM
Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
5:13 AM
Calidi Biotherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/29/2024
4:00 PM
Calidi Biotherapeutics (Filer)
Form 424B5
11/18/2024
7:10 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:02 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
5:03 AM
Calidi Biotherapeutics (Filer)
Form 424B5
11/14/2024
5:21 AM
Calidi Biotherapeutics (Filer)
Form 424B5
11/12/2024
4:08 PM
Calidi Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2024
9:05 AM
Calidi Biotherapeutics (Subject)
NYSE AMERICAN LLC (Filed by)
Form 25-NSE
10/24/2024
4:18 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
8:38 AM
Calidi Biotherapeutics (Filer)
Form 424B5
10/23/2024
7:25 AM
Calidi Biotherapeutics (Filer)
Form 424B5
10/18/2024
4:25 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
4:29 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
8:14 PM
Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
8:14 PM
Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
8:14 PM
Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
8:14 PM
Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2024
4:05 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
11:15 PM
Calidi Biotherapeutics (Filer)
Form EFFECT
09/30/2024
5:53 PM
Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
8:10 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
5:10 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
5:12 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
3:04 PM
Calidi Biotherapeutics (Subject)
Funicular Funds, LP (Filed by)
Form SC 13G
08/22/2024
4:16 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
5:04 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:CLDI) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners